logo
KKR Making Competing Bid for Equipment Maker Spectris

KKR Making Competing Bid for Equipment Maker Spectris

KKR KKR -1.64%decrease; red down pointing triangle is preparing a bid for Spectris, a U.K. maker of high-tech equipment and software, according to people familiar with the matter.
The private-equity giant would be bidding against rival Advent International, which submitted a proposal valuing Spectris at £37.63 per share, or about $5 billion, the company confirmed Monday.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

PayPoint Full Year 2025 Earnings: EPS: UK£0.27 (vs UK£0.49 in FY 2024)
PayPoint Full Year 2025 Earnings: EPS: UK£0.27 (vs UK£0.49 in FY 2024)

Yahoo

time36 minutes ago

  • Yahoo

PayPoint Full Year 2025 Earnings: EPS: UK£0.27 (vs UK£0.49 in FY 2024)

Revenue: UK£310.7m (up 4.3% from FY 2024). Net income: UK£19.2m (down 46% from FY 2024). Profit margin: 6.2% (down from 12% in FY 2024). EPS: UK£0.27 (down from UK£0.49 in FY 2024). We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. All figures shown in the chart above are for the trailing 12 month (TTM) period The primary driver behind last 12 months revenue was the Pay Point segment contributing a total revenue of UK£163.6m (53% of total revenue). Notably, cost of sales worth UK£174.3m amounted to 56% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to UK£75.5m (64% of total expenses). Explore how PAY's revenue and expenses shape its earnings. Looking ahead, revenue is expected to fall by 4.9% p.a. on average during the next 3 years compared to a 18% decline forecast for the Diversified Financial industry in the United Kingdom. Performance of the British Diversified Financial industry. The company's shares are up 8.5% from a week ago. It's necessary to consider the ever-present spectre of investment risk. We've identified 4 warning signs with PayPoint (at least 1 which makes us a bit uncomfortable), and understanding these should be part of your investment process. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Investing in Cembra Money Bank (VTX:CMBN) three years ago would have delivered you a 69% gain
Investing in Cembra Money Bank (VTX:CMBN) three years ago would have delivered you a 69% gain

Yahoo

time36 minutes ago

  • Yahoo

Investing in Cembra Money Bank (VTX:CMBN) three years ago would have delivered you a 69% gain

By buying an index fund, you can roughly match the market return with ease. But if you buy good businesses at attractive prices, your portfolio returns could exceed the average market return. Just take a look at Cembra Money Bank AG (VTX:CMBN), which is up 45%, over three years, soundly beating the market return of 13% (not including dividends). On the other hand, the returns haven't been quite so good recently, with shareholders up just 36%, including dividends. So let's assess the underlying fundamentals over the last 3 years and see if they've moved in lock-step with shareholder returns. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price. During three years of share price growth, Cembra Money Bank achieved compound earnings per share growth of 1.9% per year. This EPS growth is lower than the 13% average annual increase in the share price. This indicates that the market is feeling more optimistic on the stock, after the last few years of progress. It's not unusual to see the market 're-rate' a stock, after a few years of growth. You can see below how EPS has changed over time (discover the exact values by clicking on the image). Dive deeper into Cembra Money Bank's key metrics by checking this interactive graph of Cembra Money Bank's earnings, revenue and cash flow. It is important to consider the total shareholder return, as well as the share price return, for any given stock. The TSR incorporates the value of any spin-offs or discounted capital raisings, along with any dividends, based on the assumption that the dividends are reinvested. It's fair to say that the TSR gives a more complete picture for stocks that pay a dividend. In the case of Cembra Money Bank, it has a TSR of 69% for the last 3 years. That exceeds its share price return that we previously mentioned. This is largely a result of its dividend payments! We're pleased to report that Cembra Money Bank shareholders have received a total shareholder return of 36% over one year. And that does include the dividend. That gain is better than the annual TSR over five years, which is 5%. Therefore it seems like sentiment around the company has been positive lately. Someone with an optimistic perspective could view the recent improvement in TSR as indicating that the business itself is getting better with time. Importantly, we haven't analysed Cembra Money Bank's dividend history. This free visual report on its dividends is a must-read if you're thinking of buying. We will like Cembra Money Bank better if we see some big insider buys. While we wait, check out this free list of undervalued stocks (mostly small caps) with considerable, recent, insider buying. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Swiss exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Those who invested in Aurubis (ETR:NDA) five years ago are up 66%
Those who invested in Aurubis (ETR:NDA) five years ago are up 66%

Yahoo

time36 minutes ago

  • Yahoo

Those who invested in Aurubis (ETR:NDA) five years ago are up 66%

Aurubis AG (ETR:NDA) shareholders might be concerned after seeing the share price drop 14% in the last quarter. On the bright side the returns have been quite good over the last half decade. It has returned a market beating 51% in that time. So let's assess the underlying fundamentals over the last 5 years and see if they've moved in lock-step with shareholder returns. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement. Over half a decade, Aurubis managed to grow its earnings per share at 32% a year. The EPS growth is more impressive than the yearly share price gain of 9% over the same period. So it seems the market isn't so enthusiastic about the stock these days. The reasonably low P/E ratio of 8.82 also suggests market apprehension. The image below shows how EPS has tracked over time (if you click on the image you can see greater detail). We're pleased to report that the CEO is remunerated more modestly than most CEOs at similarly capitalized companies. But while CEO remuneration is always worth checking, the really important question is whether the company can grow earnings going forward. Before buying or selling a stock, we always recommend a close examination of historic growth trends, available here.. When looking at investment returns, it is important to consider the difference between total shareholder return (TSR) and share price return. The TSR incorporates the value of any spin-offs or discounted capital raisings, along with any dividends, based on the assumption that the dividends are reinvested. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. As it happens, Aurubis' TSR for the last 5 years was 66%, which exceeds the share price return mentioned earlier. The dividends paid by the company have thusly boosted the total shareholder return. Aurubis provided a TSR of 15% over the last twelve months. But that return falls short of the market. The silver lining is that the gain was actually better than the average annual return of 11% per year over five year. This could indicate that the company is winning over new investors, as it pursues its strategy. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Take risks, for example - Aurubis has 2 warning signs (and 1 which is concerning) we think you should know about. But note: Aurubis may not be the best stock to buy. So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast). Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on German exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store